This corporate symposium brings together clinical, translational, and research perspectives to explore how genomics is advancing oncology - from real-world implementation to next-generation biomarker discovery.
Hear directly from leading institutes and partners working at the forefront of clinical diagnostics, comparative genomics, and multi-omics innovation.
Venue
Room A3
Date & Time
Saturday 13 June 12:15 - 13:30
Lunch
Lunch Provided
Meet our corporate satellite speakers who are at the forefront of genomics innovation
Dr. Jorge Lima
Dr. Andreas Braun
Prof Giorgio Valle
Vice-Director, IPATIMUP (Portugal)
CEO, BMR Genomics | Professor, University of Padua (Italy)
Doctor of Medicine | Fellow, University Magdeburg (Germany)
Implementing NGS in Clinical Oncology Diagnostics
Exome Sequencing and Microarray Comparison in Pharmacogenomics
Powered by DNBSEQ™ technology and SM2.0 chemistry, the T7+ enables rapid, cost-efficient sequencing at scale - supporting demanding genomics applications from research to clinical workflows.
Designed for population genomics and high-throughput sequencing, the T7+ delivers the scale, speed, and accuracy needed for next-generation research.
• Up to 14 Tb per run • >40B reads per run • Q40+ accuracy • Fully automated modular workflow